Horizon Pharma plc to Host Fourth Quarter 2015 Conference Call and Webcast on February 29, 2016

Horizon Pharma plc to Host Fourth Quarter 2015 Conference Call and Webcast on February 29, 2016

ID: 447339

(firmenpresse) - DUBLIN, IRELAND -- (Marketwired) -- 01/29/16 -- Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced today that its fourth quarter 2015 financial results will be released on Monday, February 29, 2016. Following the announcement, Horizon's management will host a live conference call and webcast at 8 a.m. Eastern Time to review the Company's financial and operating results.

The live webcast and a replay may be accessed by visiting Horizon's website at . Please connect to the Company's website at least 15 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast. Alternatively, please call 1-888-338-8373 (U.S.) or 973-872-3000 (international) to listen to the conference call. The conference ID number for the live call is 39817228. Telephone replay will be available approximately two hours after the call. To access the replay, please call 1-855-859-2056 (U.S.) or 404-537-3406 (international). The conference ID number for the replay is 39817228.

Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets nine medicines through its orphan, primary care and rheumatology business units. Horizon Pharma's global headquarters are in Dublin, Ireland. For more information, please visit . Follow on Twitter or view careers on our page.



Investors:
John Thomas
Executive Vice President, Strategy and Investor Relations


Tina Ventura
Vice President, Investor Relations


U.S. Media:
Geoff Curtis
Senior Vice President, Corporate Communications


Ireland Media:




Ray Gordon
Gordon MRM

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Corcept Therapeutics Announces Preliminary Fourth Quarter and Full Year 2015 Summary Financial Results, Provides 2016 Revenue Guidance and Corporate Update Proteostasis Therapeutics Receives FDA Fast Track Designation for PTI-428 in Patients With Cystic Fibrosis
Bereitgestellt von Benutzer: Marketwired
Datum: 29.01.2016 - 12:00 Uhr
Sprache: Deutsch
News-ID 447339
Anzahl Zeichen: 0

contact information:
Town:

DUBLIN, IRELAND



Kategorie:

Drugs



Diese Pressemitteilung wurde bisher 283 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Horizon Pharma plc to Host Fourth Quarter 2015 Conference Call and Webcast on February 29, 2016"
steht unter der journalistisch-redaktionellen Verantwortung von

Horizon Pharma plc (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Horizon Pharma plc



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z